SEC Form 4 · accession 0001140361-15-035344
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael J. Farrell
Officer — Chief Executive Officer
Period of report
Sep 15, 2015
Accepted (ET)
Sep 17, 2015 · 8:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common StockF1 | Sep 15, 2015 | M | 5,975 | $15.52 | A | 178,345 | D | |
| ResMed Common Stock | Sep 15, 2015 | S | 5,975 | $50.89 | D | 172,370 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock OptionsF2 | $15.52 | Sep 15, 2015 | M | 5,975 | D | Nov 20, 2009 | Nov 20, 2015 | ResMed Commmon Stock | 5,975 | 5,975 | D |
Explanation of responses
- F1The transaction was conducted under a 10b5-1 Plan as defined under the Securities Exchange Act of 1934, as amended.
- F2Represents date options first became exercisable. Options vest 1/4 annually.